PUBLISHER: The Business Research Company | PRODUCT CODE: 1712356
PUBLISHER: The Business Research Company | PRODUCT CODE: 1712356
Cell culture consumables and equipment serve as essential tools for researchers engaged in cell culture activities, including applications in drug development, tissue engineering, gene therapy, vaccine production, and toxicity testing.
The primary categories within the cell culture consumables and equipment market encompass consumables and instruments. Cell culture instruments consist of various equipment used in cell culture laboratories, including cell culture vessels, bioreactors, biosafety cabinets, carbon dioxide incubators, and centrifuges. Consumables comprise essential supplies like media, sera, and reagents. These products find applications in a wide range of fields, including vaccination, toxicity testing, cancer research, drug screening and development, recombinant products, stem cell technology, regenerative medicine, among others. These tools cater to a diverse set of end-users, spanning industrial, biotechnology, agriculture, and more.
The cell culture consumables and equipment market research report is one of a series of new reports from The Business Research Company that provides cell culture consumables and equipment market statistics, including cell culture consumables and equipment industry global market size, regional shares, competitors with a cell culture consumables and equipment market share, detailed cell culture consumables and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture consumables and equipment industry. This cell culture consumables and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell culture consumables and equipment market size has grown rapidly in recent years. It will grow from $13.35 billion in 2024 to $14.69 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing demand for biopharmaceutical research, growth in regenerative medicine, vaccine development, growing demand for vaccines, rising prevalence of chronic diseases, increasing government funding for research and development.
The cell culture consumables and equipment market size is expected to see rapid growth in the next few years. It will grow to $22.65 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to infectious disease research, growing demand for biologics, research into rare diseases, rise in personalized medicine, advanced therapies, cell-based assays, demand for stem cell therapies. Major trends in the forecast period include advances in cell culture technology, 3d cell culture, organoid culture, bioprocess automation, single-use bioreactors, cultured meat, drug screening and toxicity testing, artificial intelligence and machine learning, cell culture in space and bioprinting.
The growing prevalence of chronic diseases is fueling the expansion of the cell culture consumables and equipment market. Chronic conditions like cancer, diabetes, heart diseases, obesity, and hypertension are on the rise, with some being linked to cell loss or damage. These diseases can potentially be treated by replacing damaged cells with new ones generated using cell culture consumables and equipment. Hence, the increasing occurrence of chronic diseases has created a heightened demand for such equipment that can facilitate the production of new cells outside the body's natural environment, thereby boosting market growth. For instance, as of September 2023, the World Health Organization reported that chronic diseases account for 74% of all global deaths, claiming the lives of 41 million people annually.
Augmented financial support for cancer research is anticipated to drive the growth of the cell culture consumables and equipment market in the upcoming period. Financial backing, particularly from government bodies like the National Cancer Institute, greatly influences the progress, evolution, and accessibility of cell culture consumables and equipment. For instance, in fiscal year 2023, the United States Congress allotted $7.3 billion to the National Cancer Institute, signifying an upsurge of $408 million from the previous year. As a result, the increased funding for cancer research is a significant driver for the growth of the cell culture consumables and equipment market.
The leading hindrance to the growth of the cell culture consumables and equipment market is the prevalence of contamination within cell cultures. This contamination involves the presence of detrimental foreign microorganisms or non-living elements that negatively affect the cell culture. The usage of contaminated cultures brings adverse effects, thereby limiting the expansion of this market. For example, as per an article published on MedCrave, Mycoplasma, one of the toughest contaminants to detect, showed a significant presence in a study conducted on fibroblast and keratinocyte cell lines. Out of the contaminated cultures, 32.35% had various types of contamination, with mycoplasma contamination accounting for 17.65%, followed by fungal (8.82%) and bacterial (5.88%) contaminants. Consequently, the substantial risk involved in cell culture practices poses a challenge to the growth of the cell culture consumables and equipment market.
Major companies in the cell culture consumables and equipment market are advancing technology by developing innovative biomaterials to improve cell growth and viability, enhance reproducibility, and minimize contamination risks in laboratory environments. Biomaterials are engineered substances designed to interact with biological systems for medical or biotechnological applications, including tissue engineering and implants. For instance, in August 2024, CytoSurge, a Georgia-based cell manufacturing and tissue engineering company, introduced a 3D fiber scaffold product designed specifically for cultivated meat production. This scaffold, made from GRAS (Generally Recognized As Safe) materials, is safe and edible, mimicking the natural extracellular matrix to facilitate nutrient flow and support high-density cell growth. Its scalable and customizable design makes it adaptable for diverse biotechnological applications, representing a significant step forward in tissue engineering and cell-based technologies.
Key companies within the cell culture consumables and equipment sector are intensifying their focus on the introduction of coated microplates to gain a competitive advantage in the market. Coated microplates constitute a category of laboratory equipment utilized across various biological and chemical assays. These plates are commonly composed of plastic or glass and are coated with a range of materials, including proteins, antibodies, antigens, enzymes, or chemical compounds. For instance, in April 2022, Porvair Sciences Limited, a UK-based producer of analytical laboratory instruments, launched a new line of microplates named Sero Krystal PDL. These microplates are uniquely designed to support cell growth, attachment, and viability in serum-free media. Utilizing Poly-D-Lysine (PDL), a synthetic peptide that enhances cell attachment and growth, and constructed from ultra-pure polystyrene in a controlled environment, the Sero Krystal PDL microplates facilitate consistent cell culture, particularly with challenging cell types. Their applications span various uses, including cell-based assays, high-throughput screening, and drug discovery.
In November 2022, The ANGUS Chemical Company, a US-based chemical company, acquired Expression Systems LLC for an undisclosed amount. This acquisition aimed to expand ANGUS's presence in the specialty cell culture media segment, thereby enhancing its bioprocessing capabilities. By leveraging complementary product offerings and expertise in biologics development, the acquisition positions ANGUS to better serve the biopharmaceutical research and development sector. Expression Systems LLC, a US-based biotechnology company, specializes in advanced cell culture consumables and equipment tailored for biopharmaceutical research and production.
Major companies operating in the cell culture consumables and equipment market include Becton Dickinson and Company, Corning Inc., Danaher Corporation, Eppendorf AG, HiMedia Laboratories Private Limited, Lonza Group AG, Merck KGAA, Promocell GmbH, Sartorius AG, Thermo Fisher Scientific Inc., Irvine Scientific Sales Company Inc., CellGenix GmbH, InVitria Inc., Cytiva, Bio-Techne Corporation, GenScript Biotech Corporation, Gedeon Richter Plc., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Bio-Rad Laboratories Inc., Illumina Inc., Qiagen NV, F. Hoffmann-La Roche Ltd, Norgen Biotek Corporation, Tecan Group Ltd.
North America was the largest region in the cell culture consumables and equipment market in 2024. Western Europe was the second-largest region in the global cell culture consumables and equipment market share. The regions covered in the cell culture consumables and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the cell culture consumables and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The cell culture consumables and equipment market consist of sales of flasks, tubes, dishes or cryovials, serological pipettes or centrifugation tubes, bottles, cell scrapers, strainers, coverslips, and inserts. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Culture Consumables And Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cell culture consumables and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cell culture consumables and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell culture consumables and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.